Dermata Therapeutics, Inc. (DRMA)
2.08
-0.06
(-2.80%)
USD |
NASDAQ |
Jan 09, 16:00
2.13
+0.05
(+2.40%)
After-Hours: 20:00
Dermata Therapeutics Shareholders Equity (Quarterly): 3.960M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Dynavax Technologies Corp. | 534.14M |
| Ekso Bionics Holdings, Inc. | 9.679M |
| Citius Pharmaceuticals, Inc. | 67.55M |
| Aptevo Therapeutics, Inc. | 17.39M |
| Applied Therapeutics, Inc. | -0.561M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.071M |
| Total Liabilities (Quarterly) | 1.111M |
| Current Ratio | 4.564 |